Evidence map›Paper›PMID 38271276›Full record

ArticleAdvanced healthcare materials2024

3D Stem Cell Spheroids with 2D Hetero-Nanostructures for In Vivo Osteogenic and Immunologic Modulated Bone Repair.

Xifeng Liu, Maria D Astudillo Potes, Babak Dashtdar, Areonna C Schreiber, Maryam Tilton, Linli Li, Benjamin D Elder, Lichun Lu

Open access · greenAbstract read
In one paragraph

Article in Advanced healthcare materials, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Xifeng LiuDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, 55905, USA.ORCID 0000-0002-2684-6309
Maria D Astudillo PotesDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, 55905, USA.
Babak DashtdarDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, 55905, USA.
Areonna C SchreiberDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, 55905, USA.
Maryam TiltonDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, 55905, USA.
Linli LiDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, 55905, USA.
Benjamin D ElderDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, 55905, USA.
Lichun LuDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, 55905, USA.
Mayo Clinic · US

Funding

Metastatic Spine Tumors: Minimally Invasive Fracture Risk Analysis and Treatment - MasterR01AR056212 · NIAMS · MAYO CLINIC ROCHESTER · PI Benjamin D Elder, Lichun Lu · 2008 to 2026
$6.2M
Injectable and Moldable Composite Bone Scaffolds for Spinal FusionR01AR075037 · NIAMS · MAYO CLINIC ROCHESTER · PI ELDER, BENJAMIN D, LU, LICHUN · 2019 to 2023
$2.5M
NIAMS NIH HHS R01 AR056212NIAMS NIH HHS R01 AR075037NIH HHS R01 AR056212NIH HHS R01 AR075037
6 · The paper itself

Abstract

3D stem cell spheroids have immense potential for various tissue engineering applications. However, current spheroid fabrication techniques encounter cell viability issues due to limited oxygen access for cells trapped within the core, as well as nonspecific differentiation issues due to the complicated environment following transplantation. In this study, functional 3D spheroids are developed using mesenchymal stem cells with 2D hetero-nanostructures (HNSs) composed of single-stranded DNA (ssDNA) binding carbon nanotubes (sdCNTs) and gelatin-bind black phosphorus nanosheets (gBPNSs). An osteogenic molecule, dexamethasone (DEX), is further loaded to fabricate an sdCNTgBP-DEX HNS. This approach aims to establish a multifunctional cell-inductive 3D spheroid with improved oxygen transportation through hollow nanotubes, stimulated stem cell growth by phosphate ions supplied from BP oxidation, in situ immunoregulation, and osteogenesis induction by DEX molecules after implantation. Initial transplantation of the 3D spheroids in rat calvarial bone defect shows in vivo macrophage shifts to an M2 phenotype, leading to a pro-healing microenvironment for regeneration. Prolonged implantation demonstrates outstanding in vivo neovascularization, osteointegration, and new bone regeneration. Therefore, these engineered 3D spheroids hold great promise for bone repair as they allow for stem cell delivery and provide immunoregulative and osteogenic signals within an all-in-one construct.

Indexed as

Bone RegenerationMesenchymal Stem CellsNanotubes, CarbonOsteogenesisSpheroids, CellularAnimalsDexamethasoneDNA, Single-StrandedGelatinMaleNanostructuresPhosphorusRatsRats, Sprague-DawleyTissue EngineeringDexamethasoneDNA, Single-StrandedGelatinNanotubes, CarbonPhosphorus2D materialsbone repairhetero‐nanostructures (HNSs)immunomodulationstem cell spheroids

Identifiers

PMID38271276
PMCPMC11404522
OpenAlexW4391232285

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.